Scientists, Government Clash Over Reforms in Italy

Even before the Silvio Berlusconi government took over last year, major reforms of Italy's scientific infrastructure were under way. The National Science Council (CNR), Italy's largest scientific organization that employs about 3,650 researchers and 2,680 technicians, already had embarked on a reform program to bring it in line with the other research organizations in Europe, such as the National Scientific Research Center (CNRS) in France or the Max Planck Institutes in Germany. The CNR is c

Written byAlexander Hellemans
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Even before the Silvio Berlusconi government took over last year, major reforms of Italy's scientific infrastructure were under way. The National Science Council (CNR), Italy's largest scientific organization that employs about 3,650 researchers and 2,680 technicians, already had embarked on a reform program to bring it in line with the other research organizations in Europe, such as the National Scientific Research Center (CNRS) in France or the Max Planck Institutes in Germany. The CNR is currently regrouping its 300 institutes into 100 larger units.

In addition to the reorganization, another important change being implemented is the selection of new institute directors by scientific peers and on scientific merit. The CNR reforms have tried to rectify many problems of that organization, such as bureaucracy, political promotions not based on peer review or scientific merit, big differences in salary, status among CNR employees and university researchers working with the CNR, and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies